Paul Foulger

Paul Andrew Peter Foulger currently works at Arcis Biotechnology Holdings Ltd., as Non-Executive Director, Alan Bailey (Studios) Ltd., as Director, Hansard Corporate Ltd., as Secretary, Director & Finance Director from 2013, Diablo Consulting Ltd., as Director, Wilton International Marketing Ltd., as Director, Arcis Biotechnology Ltd., as Finance Director & Director, Autoclenz Group Ltd., as Director, BCOM 429 Ltd., as Secretary & Director from 2013, Biolustre UK Ltd., as Secretary & Director from 2013, Palco Management Ltd., as Director from 2011, EKF Diagnostics Ltd., as Director, Autoclenz Holdings Ltd., as Non-Executive Director from 2015, GENinCode Plc, as CFO, Secretary & Executive Director, Penrhos Bio Ltd., as Non-Executive Director from 2021, and Altos Medical Ltd., as Director.
Mr. Foulger also formerly worked at Cielo Holdings Plc, as Director & Finance Director, Financial Development Corp.
Plc, as Finance Director, Sec Newgate UK Ltd., as Secretary & Director in 2011, MeDaVinci Plc, as Secretary, Director & Finance Director from 2010 to 2011, Curidium Medica Ltd., as Director, International Brand Licensing Plc, as Secretary & Finance Director in 2010, Boldwood Ltd., as Director & Secretary from 2004 to 2013, Autoclenz Ltd., as Non-Executive Director, First Africa Oil Plc, as Finance Director, NovaBiotics Ltd., as CFO, Finance Director & Director, Elsevier Ltd., as Chief Financial Officer & Finance Director, Marlwood Plc, as Director, Venn Life Sciences Holdings Plc, as Secretary, Executive Director & Finance Director from 2012 to 2014, Jupiter Diagnostics Holding Co. Ltd., as Director, EKF Diagnostics Holdings Plc, as Chief Financial Officer & Secretary in 2015, Orogen Plc, as Secretary from 2011 to 2012, and Predictimmune Ltd., as Chief Financial Officer.
Mr. Foulger received his Masters Business Admin degree from Warwick Business School.